203 related articles for article (PubMed ID: 19077566)
1. Prevalence of human papillomavirus and Chlamydia trachomatis infection among women attending cervical cancer screening in the Republic of Korea.
Oh JK; Franceschi S; Kim BK; Kim JY; Ju YH; Hong EK; Chang YC; Rha SH; Kim HH; Kim JH; Kim CY; Shin HR
Eur J Cancer Prev; 2009 Feb; 18(1):56-61. PubMed ID: 19077566
[TBL] [Abstract][Full Text] [Related]
2. Chlamydia trachomatis and human papillomavirus infection in Indian women with sexually transmitted diseases and cervical precancerous and cancerous lesions.
Gopalkrishna V; Aggarwal N; Malhotra VL; Koranne RV; Mohan VP; Mittal A; Das BC
Clin Microbiol Infect; 2000 Feb; 6(2):88-93. PubMed ID: 11168078
[TBL] [Abstract][Full Text] [Related]
3. Chlamydia Trachomatis Infection in High-Risk Human Papillomavirus Based on Cervical Cytology Specimen.
Sangpichai S; Patarapadungkit N; Pientong C; Ekalaksananan T; Chaiwiriyakul S; Thongbor R; Sirivech P; Jangsiriwitayakorn P; Triamwittayanon T
Asian Pac J Cancer Prev; 2019 Dec; 20(12):3843-3847. PubMed ID: 31870131
[TBL] [Abstract][Full Text] [Related]
4. Type- and age-specific distribution of human papillomavirus in women attending cervical cancer screening in Finland.
Leinonen MK; Anttila A; Malila N; Dillner J; Forslund O; Nieminen P
Br J Cancer; 2013 Nov; 109(11):2941-50. PubMed ID: 24136148
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of
Martinelli M; Musumeci R; Rizzo A; Muresu N; Piana A; Sotgiu G; Landoni F; Cocuzza C
Int J Environ Res Public Health; 2019 Sep; 16(18):. PubMed ID: 31514378
[No Abstract] [Full Text] [Related]
6. [HPV, Chlamydia trachomatis and genital mycoplasmas infections in women with low-grade squamous intraepithelial lesions (LSIL)].
Friedek D; Ekiel A; Chełmicki Z; Romanik M
Ginekol Pol; 2004 Jun; 75(6):457-63. PubMed ID: 15524422
[TBL] [Abstract][Full Text] [Related]
7. Risk-adapted primary HPV cervical cancer screening project in Wolfsburg, Germany--experience over 3 years.
Luyten A; Scherbring S; Reinecke-Lüthge A; Braun BE; Pietralla M; Theiler K; Petry KU
J Clin Virol; 2009 Nov; 46 Suppl 3():S5-10. PubMed ID: 20129072
[TBL] [Abstract][Full Text] [Related]
8. Chlamydia trachomatis and risk of cervical intraepithelial neoplasia grade 3 or worse in women with persistent human papillomavirus infection: a cohort study.
Jensen KE; Thomsen LT; Schmiedel S; Frederiksen K; Norrild B; van den Brule A; Iftner T; Kjær SK
Sex Transm Infect; 2014 Nov; 90(7):550-5. PubMed ID: 24728044
[TBL] [Abstract][Full Text] [Related]
9. Primary cervical cancer screening and triage using an mRNA human papillomavirus assay and visual inspection.
Nieves L; Enerson CL; Belinson S; Brainard J; Chiesa-Vottero A; Nagore N; Booth C; Pérez AG; Chávez-Avilés MN; Belinson J
Int J Gynecol Cancer; 2013 Mar; 23(3):513-8. PubMed ID: 23334437
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of positive screening test results and agreement between cytology and human papillomavirus testing in primary cervical cancer screening in North-Western Romania.
Şuteu O; Blaga ML; Nygård M; Leinonen MK; Nicula F; Păiş R; Coza D; Cadariu PA; Melnic A; Andreassen T; Hashim D; Weiderpass E
Eur J Cancer Prev; 2020 Mar; 29(2):141-148. PubMed ID: 31033568
[TBL] [Abstract][Full Text] [Related]
11. Design and results of the USA-Mexico border human papillomavirus (HPV), cervical dysplasia, and Chlamydia trachomatis study.
Giuliano AR; Denman C; Guernsey de Zapien J; Navarro Henze JL; Ortega L; Djambazov B; Mendez Brown de Galaz E; Hatch K
Rev Panam Salud Publica; 2001 Mar; 9(3):172-81. PubMed ID: 11349353
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and carcinogenic risk of high-risk human papillomavirus subtypes in different cervical cytology: a study of 124,251 cases from the largest academic center in China.
Tao X; Zhang H; Wang S; Chen T; Cong Q; Wang L; Zhou X; Zhao C
J Am Soc Cytopathol; 2021; 10(4):391-398. PubMed ID: 33906830
[TBL] [Abstract][Full Text] [Related]
13. Type-specific persistence and associated risk factors of human papillomavirus infections in women living in central Italy.
Sammarco ML; Del Riccio I; Tamburro M; Grasso GM; Ripabelli G
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):222-6. PubMed ID: 23395560
[TBL] [Abstract][Full Text] [Related]
14. [Association of human papillomavirus infection with other microbial pathogens in gynecology].
Zheng MY; Zhao HL; Di JP; Lin G; Lin Y; Lin X; Zheng MQ
Zhonghua Fu Chan Ke Za Zhi; 2010 Jun; 45(6):424-8. PubMed ID: 21029592
[TBL] [Abstract][Full Text] [Related]
15. Co-infection between genotypes of the human papillomavirus and
Escarcega-Tame MA; López-Hurtado M; Escobedo-Guerra MR; Reyes-Maldonado E; Castro-Escarpulli G; Guerra-Infante FM
Int J STD AIDS; 2020 Nov; 31(13):1255-1262. PubMed ID: 32998641
[TBL] [Abstract][Full Text] [Related]
16. Chlamydia trachomatis as a probable cofactor in human papillomavirus infection in aboriginal women from northeastern Argentina.
Deluca GD; Basiletti J; Schelover E; Vásquez ND; Alonso JM; Marín HM; Lucero RH; Picconi MA
Braz J Infect Dis; 2011; 15(6):567-72. PubMed ID: 22218516
[TBL] [Abstract][Full Text] [Related]
17. Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: association with human papillomavirus infection.
Tam LS; Chan AY; Chan PK; Chang AR; Li EK
Arthritis Rheum; 2004 Nov; 50(11):3619-25. PubMed ID: 15529372
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.
Ouh YT; Min KJ; Cho HW; Ki M; Oh JK; Shin SY; Hong JH; Lee JK
J Gynecol Oncol; 2018 Jan; 29(1):e14. PubMed ID: 29185272
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Chlamydia trachomatis and herpes simplex virus 2 in cervical carcinoma associated with human papillomavirus detected in paraffin-sectioned samples.
Kwaśniewska A; Korobowicz E; Zdunek M; Skoczyński M; Kwaśniewski W; Daniłoś J; Goździcka-Józefiak A
Eur J Gynaecol Oncol; 2009; 30(1):65-70. PubMed ID: 19317260
[TBL] [Abstract][Full Text] [Related]
20. HPV and Chlamydia trachomatis co-detection in young asymptomatic women from high incidence area for cervical cancer.
Bellaminutti S; Seraceni S; De Seta F; Gheit T; Tommasino M; Comar M
J Med Virol; 2014 Nov; 86(11):1920-5. PubMed ID: 25132162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
